Global Epilepsy Monitoring Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

Description

List of Tables

The global demand for Epilepsy Monitoring Devices Market is presumed to reach the market size of nearly USD 889.81 MN by 2030 from USD 584.22 MN in 2022 with a CAGR of 5.4% under the study period 2023 - 2030.

Epilepsy monitoring devices are medical devices designed to monitor and record the brain activity of individuals with epilepsy. Epilepsy is a neurological condition marked by repetitive seizures, which involve abrupt and uncontrollable surges of electrical activity within the brain. Monitoring devices play a crucial role in diagnosing, managing, and understanding epilepsy by recording and analyzing brain wave patterns, also known as electroencephalograms (EEG).

MARKET DYNAMICS:

The increasing prevalence of epilepsy and related conditions, along with greater awareness and improved diagnosis rates, has driven the demand for effective monitoring solutions. Technological advancements, such as sophisticated EEG sensors and wireless communication, have led to more advanced and user-friendly monitoring devices. Personalized treatment approaches and the capability for long-term monitoring have increased the need for accurate and comprehensive data collection. Portable and home-based monitoring options, including wearable devices, have gained popularity, allowing patients to be monitored in their daily environments. The rise of telemedicine and remote healthcare solutions has also expanded the possibilities for monitoring patients remotely. Government initiatives, infrastructure development, and growing patient and caregiver preferences for non-invasive solutions have contributed to the market's growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of epilepsy monitoring devices. The growth and trends of epilepsy monitoring devices industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the epilepsy monitoring devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Wearable Devices
Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, Emg Devices, Meg Devices, Other Monitoring Devices)

By End User

Hospitals
Ambulatory Surgery Centers & Clinics
Neurology Centres
Diagnostic Centres
Home Care Settings

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Epilepsy Monitoring Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Epilepsy Monitoring Devices market include Natus Medical, Inc (US), Compumedics Limited (Australia), Empatica, Inc. (US), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), Medtronic Plc (Ireland), Masimo Corporation (US), Boston Scientific Corporation (US), Dragerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia), Advanced Brain Monitoring (US), Lifelines Neuro Company, LLC (US), Mitsar Co., Ltd (Russia). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112112055

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . EPILEPSY MONITORING DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End User
- 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY PRODUCT

5.1 Overview by Product
5.2 Historical and Forecast Data
5.3 Analysis by Product
5.4 Wearable Devices Historic and Forecast Sales by Regions
5.5 Conventional Devices (Deep Brain Stimulation Devices, Montioring Devices, EMG Devices, MEG Devices, Other Monitoring Devices) Historic and Forecast Sales by Regions

6 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY END USER

6.1 Overview by End User
6.2 Historical and Forecast Data
6.3 Analysis by End User
6.4 Hospitals Historic and Forecast Sales by Regions
6.5 Ambulatory Surgery Centers & Clinics Historic and Forecast Sales by Regions
6.6 Neurology Centres Historic and Forecast Sales by Regions
6.7 Diagnostic Centres Historic and Forecast Sales by Regions
6.8 Home Care Settings Historic and Forecast Sales by Regions

7 . GLOBAL EPILEPSY MONITORING DEVICES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1. Overview, Historic and Forecast Data Sales Analysis
- 7.3.2. North America By Segment Sales Analysis
- 7.3.3. North America By Country Sales Analysis
- 7.3.4. United State Sales Analysis
- 7.3.5. Canada Sales Analysis
- 7.3.6. Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1. Overview, Historic and Forecast Data Sales Analysis
- 7.4.2. Europe by Segment Sales Analysis
- 7.4.3. Europe by Country Sales Analysis
- 7.4.4. United Kingdom Sales Analysis
- 7.4.5. France Sales Analysis
- 7.4.6. Germany Sales Analysis
- 7.4.7. Italy Sales Analysis
- 7.4.8. Russia Sales Analysis
- 7.4.9. Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1. Overview, Historic and Forecast Data Sales Analysis
- 7.5.2. Asia Pacific by Segment Sales Analysis
- 7.5.3. Asia Pacific by Country Sales Analysis
- 7.5.4. China Sales Analysis
- 7.5.5. India Sales Analysis
- 7.5.6. Japan Sales Analysis
- 7.5.7. South Korea Sales Analysis
- 7.5.8. Australia Sales Analysis
- 7.5.9. South East Asia Sales Analysis
- 7.5.10. Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1. Overview, Historic and Forecast Data Sales Analysis
- 7.6.2. Latin America by Segment Sales Analysis
- 7.6.3. Latin America by Country Sales Analysis
- 7.6.4. Brazil Sales Analysis
- 7.6.5. Argentina Sales Analysis
- 7.6.6. Peru Sales Analysis
- 7.6.7. Chile Sales Analysis
- 7.6.8. Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1. Overview, Historic and Forecast Data Sales Analysis
- 7.7.2. Middle East & Africa by Segment Sales Analysis
- 7.7.3. Middle East & Africa by Country Sales Analysis
- 7.7.4. Saudi Arabia Sales Analysis
- 7.7.5. UAE Sales Analysis
- 7.7.6. Israel Sales Analysis
- 7.7.7. South Africa Sales Analysis
- 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE EPILEPSY MONITORING DEVICES COMPANIES

8.1. Epilepsy Monitoring Devices Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9 . COMPANY PROFILES OF EPILEPSY MONITORING DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Natus Medical Inc (US)
- 9.3.1. Company Overview
- 9.3.2. Company Revenue
- 9.3.3. Products
- 9.3.4. Recent Developments
9.4. Compumedics Limited (Australia)
- 9.4.1. Company Overview
- 9.4.2. Company Revenue
- 9.4.3. Products
- 9.4.4. Recent Developments
9.5. Empatica Inc. (US)
- 9.5.1. Company Overview
- 9.5.2. Company Revenue
- 9.5.3. Products
- 9.5.4. Recent Developments
9.6. The Magstim Co. Ltd. (UK)
- 9.6.1. Company Overview
- 9.6.2. Company Revenue
- 9.6.3. Products
- 9.6.4. Recent Developments
9.7. Nihon Kohden Corporation (Japan)
- 9.7.1. Company Overview
- 9.7.2. Company Revenue
- 9.7.3. Products
- 9.7.4. Recent Developments
9.8. Medtronic Plc (Ireland)
- 9.8.1. Company Overview
- 9.8.2. Company Revenue
- 9.8.3. Products
- 9.8.4. Recent Developments
9.9. Masimo Corporation (US)
- 9.9.1. Company Overview
- 9.9.2. Company Revenue
- 9.9.3. Products
- 9.9.4. Recent Developments
9.10. Boston Scientific Corporation (US)
- 9.10.1. Company Overview
- 9.10.2. Company Revenue
- 9.10.3. Products
- 9.10.4. Recent Developments
9.11. Dragerwerk AG & Co. KGaA (Germany)
- 9.11.1. Company Overview
- 9.11.2. Company Revenue
- 9.11.3. Products
- 9.11.4. Recent Developments
9.12. mjn Neuroserveis S.L. (Spain)
- 9.12.1. Company Overview
- 9.12.2. Company Revenue
- 9.12.3. Products
- 9.12.4. Recent Developments
9.13. Abbott Laboratories Inc. (US)
- 9.13.1. Company Overview
- 9.13.2. Company Revenue
- 9.13.3. Products
- 9.13.4. Recent Developments
9.14. LivAssured B.V. (Netherlands)
- 9.14.1. Company Overview
- 9.14.2. Company Revenue
- 9.14.3. Products
- 9.14.4. Recent Developments
9.15. BioSerenity (France)
- 9.15.1. Company Overview
- 9.15.2. Company Revenue
- 9.15.3. Products
- 9.15.4. Recent Developments
9.16. Aleva Neurotherapeutics (Switzerland)
- 9.16.1. Company Overview
- 9.16.2. Company Revenue
- 9.16.3. Products
- 9.16.4. Recent Developments
9.17. Medpage Ltd. (UK)
- 9.17.1. Company Overview
- 9.17.2. Company Revenue
- 9.17.3. Products
- 9.17.4. Recent Developments
9.18. Neurosoft (Russia)
- 9.18.1. Company Overview
- 9.18.2. Company Revenue
- 9.18.3. Products
- 9.18.4. Recent Developments
9.19. Advanced Brain Monitoring (US)
- 9.19.1. Company Overview
- 9.19.2. Company Revenue
- 9.19.3. Products
- 9.19.4. Recent Developments
9.20. Lifelines Neuro Company LLC (US)
- 9.20.1. Company Overview
- 9.20.2. Company Revenue
- 9.20.3. Products
- 9.20.4. Recent Developments
9.21. Mitsar Co. Ltd (Russia)
- 9.21.1. Company Overview
- 9.21.2. Company Revenue
- 9.21.3. Products
- 9.21.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies